Showing results (131-140 of 499) with videos related to

Sort By:
Pageof 50
Cell & Bioscience|July 9, 2021
A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronavirusesYanxing Cai, Wei Xu, Jiayi Tang, et al.
Viruses|July 27, 2022
Network Pharmacology and Molecular Docking Elucidate the Underlying Pharmacological Mechanisms of the Herb Houttuynia cordata in Treating Pneumonia Caused by SARS-CoV-2Junying Liu, Shouli Yuan, Yao Yao, et al.
Current Research in Microbial Sciences|April 3, 2025
Genomic signatures and host adaptation of H5N1 clade 2.3.4.4b: A call for global surveillance and multi-target antiviral strategiesGuangxu Zhang, Yuren Shi, Haoyu Ge, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2012
3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entryLin Li, Jiayin Qiu, Lu Lu, et al.
Vaccine|May 27, 2006
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccineYuxian He, Jingjing Li, Lanying Du, et al.
Viruses|December 30, 2015
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) EntryWenjiao Wu, Richan Li, Xianglian Li, et al.
Biochemical and Biophysical Research Communications|December 15, 2018
Characterization by high-resolution crystal structure analysis of a triple-helix region of human collagen type III with potent cell adhesion activityChen Hua, Yun Zhu, Wei Xu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 23, 2014
Peptidic HIV-1 fusion inhibitor VIR576 as a potential dual- functional microbicide inhibits antigen-specific CD4(+) T-cell activationMinmin Li, Ruitao Zhang, Yiping Hu, et al.
Frontiers in Immunology|March 20, 2023
Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infectionTianyu Lu, Qiuhong Man, Xueying Yu, et al.
Biochemical and Biophysical Research Communications|October 12, 2004
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccineYuxian He, Yusen Zhou, Shuwen Liu, et al.
Pageof 50